Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26989
Title: The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile.
Austin Authors: Berthelet, Jean;Wimmer, Verena C;Whitfield, Holly J;Serrano, Antonin;Boudier, Thomas;Mangiola, Stefano;Merdas, Michal;El-Saafin, Farrah;Baloyan, David;Wilcox, Jordan;Wilcox, Steven;Parslow, Adam C;Papenfuss, Anthony T;Yeo, Belinda ;Ernst, Matthias ;Pal, Bhupinder;Anderson, Robin L ;Davis, Melissa J;Rogers, Kelly L;Hollande, Frédéric;Merino, Delphine
Affiliation: Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia
Department of Medical Biology, Faculty of Medicine, Dentistry, and Health Science, The University of Melbourne, Parkville, VIC 3010, Australia
Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia
Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3000, Australia
Olivia Newton-John Cancer Research Institute
School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia
Austin Health
Department of Clinical Pathology, Faculty of Medicine, Dentistry, and Health Science, The University of Melbourne, Melbourne, VIC 3000, Australia
Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia
University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Melbourne, VIC 3000, Australia
Issue Date: 2021
Date: 2021-07-07
Publication information: Science advances 2021; 7(28)
Abstract: Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition of thousands of metastases in two clinically relevant sites, the lungs and liver, we found that metastases were highly polyclonal in lungs but not in the liver. Furthermore, the transcriptome of the subclones varied according to their metastatic niche. We also identified a reversible niche-driven signature that was conserved in lung and liver metastases collected during patient autopsies. Among this signature, we found that the tumor necrosis factor-α pathway was up-regulated in lung compared to liver metastases, and inhibition of this pathway affected metastasis diversity. These results highlight that the cellular and molecular heterogeneity observed in metastases is largely dictated by the tumor microenvironment.
URI: https://ahro.austin.org.au/austinjspui/handle/1/26989
DOI: 10.1126/sciadv.abf4408
ORCID: 0000-0003-2562-0575
0000-0002-9931-8179
0000-0002-7282-387X
0000-0002-8178-6441
0000-0002-0148-7733
0000-0001-7474-836X
0000-0003-3257-9953
0000-0002-1650-8007
0000-0002-0585-9573
0000-0002-9868-6914
0000-0002-1102-8506
0000-0002-9218-9917
0000-0003-4864-7033
0000-0002-6755-0221
0000-0002-7046-8392
0000-0002-8075-6275
Journal: Science Advances
PubMed URL: 34233875
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

44
checked on Sep 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.